How to buy Phio Pharmaceuticals stock | $2.22

Phio Pharmaceuticals Corp is a biotechnology business based in the US. Phio Pharmaceuticals shares (PHIO) are listed on the NASDAQ and all prices are listed in US Dollars. Phio Pharmaceuticals employs 10 staff and has a market cap (total outstanding shares value) of 0.00.

Phio Pharmaceuticals stock price (NASDAQ: PHIO)

Use our graph to track the performance of PHIO stocks over time.

Phio Pharmaceuticals shares at a glance

• Key figures

Information last updated 2021-07-28.

Latest market close	$2.22
52-week range	$1.72 - $4.36
50-day moving average	$2.10
200-day moving average	$2.57
Wall St. target price	$6.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.45

Buy Phio Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Phio Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Phio Pharmaceuticals Corp by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Phio Pharmaceuticals price performance over time

Historical closes compared with the close of $2.22 from 2021-05-28

1 week (2021-07-24)	N/A
1 month (2021-07-02)	2.78%
3 months (2021-05-04)	2.22
6 months (2021-01-31)	N/A

1 year (2020-07-31)	N/A
2 years (2019-07-31)	N/A
3 years (2018-07-31)	N/A
5 years (2016-07-31)	N/A

Phio Pharmaceuticals financials

Gross profit TTM	$-4,431,000
Return on assets TTM	-26.15%
Return on equity TTM	-45.41%
Profit margin	0%
Book value	$2.32
Market capitalisation	$24.8 million

TTM: trailing 12 months

Shorting Phio Pharmaceuticals shares

There are currently 1.1 million Phio Pharmaceuticals shares held short by investors – that's known as Phio Pharmaceuticals's "short interest". This figure is 8.6% up from 1.1 million last month.

There are a few different ways that this level of interest in shorting Phio Pharmaceuticals shares can be evaluated.

Phio Pharmaceuticals's "short interest ratio" (SIR)

Phio Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Phio Pharmaceuticals shares currently shorted divided by the average quantity of Phio Pharmaceuticals shares traded daily (recently around 318729.05027933). Phio Pharmaceuticals's SIR currently stands at 3.58. In other words for every 100,000 Phio Pharmaceuticals shares traded daily on the market, roughly 3580 shares are currently held short.

However Phio Pharmaceuticals's short interest can also be evaluated against the total number of Phio Pharmaceuticals shares, or, against the total number of tradable Phio Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Phio Pharmaceuticals's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Phio Pharmaceuticals shares in existence, roughly 80 shares are currently held short) or 0.0846% of the tradable shares (for every 100,000 tradable Phio Pharmaceuticals shares, roughly 85 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Phio Pharmaceuticals.

Find out more about how you can short Phio Pharmaceuticals stock.

Phio Pharmaceuticals share dividends

We're not expecting Phio Pharmaceuticals to pay a dividend over the next 12 months.

Have Phio Pharmaceuticals's shares ever split?

Phio Pharmaceuticals's shares were split on a 1:55 basis on 14 January 2020. So if you had owned 55 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Phio Pharmaceuticals shares – just the quantity. However, indirectly, the new 5400% higher share price could have impacted the market appetite for Phio Pharmaceuticals shares which in turn could have impacted Phio Pharmaceuticals's share price.

Phio Pharmaceuticals share price volatility

Over the last 12 months, Phio Pharmaceuticals's shares have ranged in value from as little as $1.72 up to $4.36. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Phio Pharmaceuticals's is 2.2116. This would suggest that Phio Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Phio Pharmaceuticals overview

Phio Pharmaceuticals Corp. , a biotechnology company, develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on silencing tumor-induced suppression of the immune system. The company develops PH-762, which targets the checkpoint protein PD-1 that prevent T cells from attacking various cells for used in adoptive cell transfer (ACT); PH-804 that targets the suppressive immune receptor TIGIT, which is a checkpoint protein present on T cells and natural killer cells for used in ACT; and PH-790 which targets PD-L1 protein that prevent cancer cells from inactivating T cells and attack the cancer. It has collaboration with AgonOx, Inc. on clinical development of novel immunotherapy drugs targeting key regulators of the immune response to cancer. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp.

Frequently asked questions

What percentage of Phio Pharmaceuticals is owned by insiders or institutions?
Currently 0.288% of Phio Pharmaceuticals shares are held by insiders and 7.93% by institutions. How many people work for Phio Pharmaceuticals?
Latest data suggests 10 work at Phio Pharmaceuticals. When does the fiscal year end for Phio Pharmaceuticals?
Phio Pharmaceuticals's fiscal year ends in December. Where is Phio Pharmaceuticals based?
Phio Pharmaceuticals's address is: 257 Simarano Drive, Marlborough, MA, United States, 01752 What is Phio Pharmaceuticals's ISIN number?
Phio Pharmaceuticals's international securities identification number is: US71880W3034 What is Phio Pharmaceuticals's CUSIP number?
Phio Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 71880W204